Details for New Drug Application (NDA): 209076
✉ Email this page to a colleague
The generic ingredient in IBUPROFEN is ibuprofen sodium. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
Summary for 209076
Tradename: | IBUPROFEN |
Applicant: | Ultratab Labs Inc |
Ingredient: | ibuprofen |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209076
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jan 6, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription